[1]田玥,苏成海.恶性肿瘤的放射治疗联合基因治疗研究进展[J].国际放射医学核医学杂志,2008,32(1):43-46.
 TIAN Yue,SU Cheng-hai.Advancement of researches on the malignant tumor radio-genetic therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(1):43-46.
点击复制

恶性肿瘤的放射治疗联合基因治疗研究进展(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
32
期数:
2008年第1期
页码:
43-46
栏目:
放射生物学
出版日期:
1900-01-01

文章信息/Info

Title:
Advancement of researches on the malignant tumor radio-genetic therapy
作者:
田玥 苏成海
215006 苏州, 苏州大学附属第一医院核医学科
Author(s):
TIAN Yue SU Cheng-hai
Department of Nuclear Medicine, the First Affiliated Hospital of Suzhou University, Suzhou 215006, China
关键词:
放射疗法基因疗法肿瘤治疗方案
Keywords:
RadiotherapyGene therapyAntineoplastic protocols
分类号:
R730.5
摘要:
放射治疗是恶性肿瘤治疗的常规手段之一,并早已用于临床。而基因治疗是一种新型的治疗方法,但由于肿瘤的形成是多因素、多基因参与的复杂过程,单纯基因治疗的效果并不理想。因此,放射治疗联合基因治疗是目前的研究热点,也将成为肿瘤治疗研究的重要方向之一。
Abstract:
Radiotherapy is one of the routine methods of malignant tumor treatment and used in clinical many years, while gene therapy is one of the new therapy. But the formation of tumor is the complicated process effected by many factors and many genes. The effect of polygene therapy is not ideal. Therefore, radio-genetic therapy is the hot spot of the present study and will become one of the important direction of cancer therapy.

参考文献/References:

[1] Connell PP, Weichselbaum RR. Gene therapy:the challenges of translating laboratory research into clinical practice[J]. J Clin Oncol, 2003, 21(12):2230-2231.
[2] Weichselbaum RR, Hallahan DE, Beckett MA, et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells[J]. Cancer nes, 1994, 54(16):4266-4269.
[3] Seethram S, Staba MJ, Schumm IP, et al. Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation[J]. Int J Oncol, 1999, 15(4):769-773.
[4] Gridley DS, Baer JR, Cao JD, et al. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model[J]. Int J Oncol, 2002, 21(2):251-259.
[5] Sherman ML, Datta R, Hallahan DE. Ionizing radiation regulates expression of the c-jun protooncogene[J]. Natl Acad Sci USA, 1990, 87(15):5663-5670.
[6] Xian J, Yang H, Lin Y, et al. Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2005, 131(12):1079-1085.
[7] Haupt S, Haupt Y. Importance of p53 for cancer onset and therapy[J]. Anti Cancer Drugs, 2006, 17(7):725-732.
[8] Mimeault M, Batra SK. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies[J]. Carcinogenesis, 2006, 27(1):1-22.
[9] Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild-type p53[J]. Science, 1990, 249(4971):912-915.
[10] Guha A, Mukherjee J. Advances in the biology of astrocytomas[J]. Curr Opin Neurol, 2004, 17(6):655-662.
[11] 张珊文,肖绍文,刘长清,等.头颈鳞癌基因治疗结合放射治疗的临床研究[J].中华肿瘤杂志,2005,27(7):426-428.
[12] Tan PH, Chan CL, Chan C, et al. The evolving role of gene-based treatment in surgery[J]. Br J Surg, 2005, 92(12):1466-1480.
[13] Vlachaki MT, Chhikara M, Aguilar L, et al. Enhanced therapeutic effect of multiple injections of HSV-TK+GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model[J]. Int J Radiat Oncol Biol Phys, 2001, 51(4):1008-1017.
[14] Chhikara M, Huang H, Vlachaki MT, et al. Enhanced therapeutic effect of HSV-TK+GCV gene therapy and ionizing radiation for prostate cancer[J]. Mol Ther, 2001, 3(4):536-542.
[15] Rogulski KR, Wing MS, Paielli DL, et al. Double suicide gene therapy augments the antitumor activity of a replication-competent-lytic adenovirus through enhanced cytotoxicity and radiosensitization[J]. Hum Gene Ther, 2000, 11(1):67-76.
[16] 李勇,金宁,杨海山,等.内皮抑素基因联合放射治疗对大鼠Walker-256细胞种植性肿瘤的抑制作用[J].中华放射医学与防护杂志,2005,25(6):531-533.
[17] 隋刚,徐志飞,孙耀昌,等.内皮抑素基因治疗对小鼠肿瘤组织内新生血管形成抑制作用的实验研究[J].中华肿瘤防治杂志,2006,13(12):904-907.
[18] Ma B, Bristow RG, Kim J, et al. Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents[J]. J Clin Oncol, 2003, 21(14):2760-2776.
[19] Wu C, Li Xi, Tian M, et al. Effect of pEgr-TNF[alpha] gene radiotherapy on mice melanoma[J]. Cancer Res, 2005, 15(3):185-190.
[20] Quentin T, Henke C, Korabiowska M, et al. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression[J]. Anticancer Res, 2004, 24(2):1011-1023.
[21] Liu LL, Wang JH, Sun BS, et al. Combined IFN-gamma-endostatin gene-therapy and radio-therapy attanuates primary breast tumour growth and lung metastases in a murine model via enhanced CTL and NK cell activation and attenuated tumour angiogenesis:9565[J]. Br J Surg, 2006, 93(S3):11-12.
[22] 杨巍,吴丛梅,李修义,等.pEgr-IFNγ重组质粒辐射诱导表达及其抑瘤作用的实验研究[J].中华放射医学与防护杂志,2003,23(4):238-240.
[23] Greenberger JS, Bahri S, Jett J, et al. Consideration in optimizing radiation therapy for non-small cell lung cancer[J]. Chest, 1998, 113(1Suppl):46-52.
[24] Collis SJ, Ketner GW, Hicks JL, et al. Expression of the DNA-PK binding protein E4-34K fails to confer radiation sensitivity to mammalian cells[J]. Int J Radiat Biol, 2003, 79(1):53-60.

相似文献/References:

[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
 Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
 Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
 Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
 Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
 Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
 Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
 zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[8]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
 Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[9]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
 Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[10]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
 Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[11]王芹,王敬敏,徐畅,等.Ad-Rb94联合照射对体外人大肠癌细胞的抑瘤作用[J].国际放射医学核医学杂志,2014,38(6):351.[doi:10.3760/cma.j.issn.1673-4114.2014.06.001]
 Wang Qin,Wang Jing-min,Xu Chang,et al.The effect of Ad-Rb94 combined with radiation on inhibiting the growth of human colorectal cancer cells in vitro[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):351.[doi:10.3760/cma.j.issn.1673-4114.2014.06.001]
[12]王芹,刘晓秋,李进,等.白细胞介素21基因联合不同剂量γ射线照射对乳腺癌细胞生长的影响[J].国际放射医学核医学杂志,2012,36(2):94.[doi:10.3760/cma.j.issn.1673-4114.2012.02.009]
 WANG Qin,LIU Xiao-qiu,LI Jin,et al.Effects of interleukin-21 gene combined with different doses of γ-ray radiation on growth of breast carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):94.[doi:10.3760/cma.j.issn.1673-4114.2012.02.009]
[13]陈凤华,李进,谭志军,等.Ad-Rb94联合γ射线照射对食管癌细胞生长的影响[J].国际放射医学核医学杂志,2010,34(2):119.[doi:10.3760/cma.j.issn.1673-4114.2010.02.017]
 CHEN Feng-hua,LI Jin,TAN Zhi-jun,et al.Effects of recombinant adenovirus mediated retinoblastoma gene 94 combined with γ-ray on growth of esophageal carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):119.[doi:10.3760/cma.j.issn.1673-4114.2010.02.017]
[14]翟红彦,苏成海.基因治疗联合放射治疗恶性肿瘤的分子机制[J].国际放射医学核医学杂志,2009,33(2):113.[doi:10.3760/cma.j.issn.1673-4114.2009.02.015]
 ZHAI Hong-yan,SU Cheng-hai.Molecular mechanism of genetherapy combined radiotherapy for malignant tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(1):113.[doi:10.3760/cma.j.issn.1673-4114.2009.02.015]
[15]张耀文,曹永珍,李进,等.基因治疗联合放射治疗恶性肿瘤[J].国际放射医学核医学杂志,2008,32(4):247.
 ZHANG Yao-wert,CAO Yong-zhen,LI Jin,et al.Gene therapy and radiotherapy in malignant tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(1):247.
[16]赵艳芝,李进,王芹,等.恶性肿瘤基因治疗和放射治疗相互作用的机制及联合治疗展望[J].国际放射医学核医学杂志,2006,30(4):250.
 ZHAO Yan-zhi,LI Jin,WANG Qin,et al.The mechanisms of inter-effect about gene therapy and raidotherapy to tumor and the prospect of therapeutic alliance[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):250.
[17]陈冀莹.宫颈癌基因治疗联合放射治疗的研究进展[J].国际放射医学核医学杂志,2006,30(6):365.
 CHEN Ji-ying.Progress of cervical cancer genetic-radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):365.
[18]张春智,郭阳,吕仲宏.辐射敏感性早期生长应答-1基因启动子的研究[J].国际放射医学核医学杂志,2006,30(2):120.
 ZHANG Chun-zhi,GUO Yang,LÜ,et al.The study on Egr-1 promoter which is radioactive promoter[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):120.

备注/Memo

备注/Memo:
收稿日期:2007-07-19。
通讯作者:苏成海,E-mail:su323@126.com
更新日期/Last Update: 1900-01-01